A second magnificent ultra-high-yield dividend stock that's begging to be bought in November is pharmaceutical titan Pfizer (NYSE: PFE), which is currently sporting an impressive 7% annual yield.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results